NATERA INC (NTRA) Stock News

USA - NASDAQ:NTRA - US6323071042 - Common Stock

163.84 USD

+0.87 (+0.53%)

Last: 9/29/2025, 12:36:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NTRA Latest News, Press Relases and Analysis

All

Press Releases

5 hours ago - By: Natera, Inc.

Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows

5 days ago - By: Benzinga

Here's How Much $1000 Invested In Natera 5 Years Ago Would Be Worth Today

6 days ago - By: Benzinga

How Do Investors Really Feel About Natera?

a month ago - By: Yahoo Finance - Mentions: NEO NFLX

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

a month ago - By: Natera, Inc.

Natera Provides Update on Patent Litigation with NeoGenomics

a month ago - By: Natera, Inc.

Signatera™ Test Selected for NRG-Sponsored Phase III ARCHER Trial in Bladder Cancer

a month ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

Natera Shares Rise on the Launch of AI Platform for Precision Oncology

a month ago - By: Natera, Inc.

Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

a month ago - By: Natera, Inc.

Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine

a month ago - By: Natera, Inc.

Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation

a month ago - By: Natera, Inc.

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

2 months ago - By: Zacks Investment Research

Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics